Literature DB >> 12682712

Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.

A C Parrott, T Buchanan, T M Heffernan, A Scholey, J Ling, J Rodgers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12682712     DOI： 10.1007/s00213-003-1447-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  13 in total

1.  Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

Authors:  S J Peroutka; H Newman; H Harris
Journal:  Neuropsychopharmacology       Date:  1988-12       Impact factor: 7.853

2.  Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

Authors:  A C Parrott; T Buchanan; A B Scholey; T Heffernan; J Ling; J Rodgers
Journal:  Hum Psychopharmacol       Date:  2002-08       Impact factor: 1.672

Review 3.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

4.  Parkinson's disease. Clues to aetiology from a toxin.

Authors:  S H Snyder
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

5.  Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease.

Authors:  J W Langston; P Ballard
Journal:  Can J Neurol Sci       Date:  1984-02       Impact factor: 2.104

6.  Cognitive performance amongst recreational users of "ecstasy".

Authors:  J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2000-07       Impact factor: 4.530

7.  Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

Authors:  G C Davis; A C Williams; S P Markey; M H Ebert; E D Caine; C M Reichert; I J Kopin
Journal:  Psychiatry Res       Date:  1979-12       Impact factor: 3.222

8.  Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Authors:  A C Parrott; J Lasky
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

9.  Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.

Authors:  D B Calne; J W Langston; W R Martin; A J Stoessl; T J Ruth; M J Adam; B D Pate; M Schulzer
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

10.  Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy").

Authors:  George A Ricaurte; Jie Yuan; George Hatzidimitriou; Branden J Cord; Una D McCann
Journal:  Science       Date:  2002-09-27       Impact factor: 47.728
View more
  2 in total

1.  Editorial note: MDMA-induced dopamine neurotoxicity.

Authors:  David M Warburton
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

2.  MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.

Authors:  Giulia Costa; Nicola Simola; Micaela Morelli
Journal:  Psychopharmacology (Berl)       Date:  2014-04-01       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.